Regulations.gov document
Tab 1/Exhibit 1 - "FDA/CDER Response to King Pharmaceuticals, July 29, 2009, re Docket IDs…
Supporting & Related Material · FDA-2009-P-0597 · posted Dec 29, 2009
Key facts
| Document ID | FDA-2009-P-0597-0003 |
|---|---|
| Title | Tab 1/Exhibit 1 - "FDA/CDER Response to King Pharmaceuticals, July 29, 2009, re Docket IDs FDA-2007-P-0128 and FDA-2009-P-0040" - [GlaxoSmithKline (Ropes & Gray LLP) - Citizen Petition] |
| Document type | Supporting & Related Material |
| Subtype | CP-Citizen Petition (Supporting & Related Materials) |
| Agency | FDA |
| Docket | FDA-2009-P-0597 |
| Posted | Dec 29, 2009 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: